feed,title,long_url,short_url
Benzinga,EMA's Advisory Committee Recommends Approval Of Bristol-Myers' Breyanzi In Lymphoma,https://benzinga.com/general/biotech/22/01/25286078/emas-advisory-committee-recommends-approval-of-bristol-myers-breyanzi-in-lymphoma,https://bit.ly/3HaHaQ1
Benzinga,EMA's Advisory Committee Recommends Approval Of Blueprint Medicines' Avapritinib In Blood Disorder,https://benzinga.com/general/biotech/22/01/25285602/emas-advisory-committee-recommends-approval-of-blueprint-medicines-avapritinib-in-blood-disorder,https://bit.ly/3uon8hJ
Benzinga,Eli Lilly Plans To Invest â‚¬400M In Manufacturing Facility In Ireland: Report,https://benzinga.com/general/biotech/22/01/25285176/eli-lilly-plans-to-invest-400m-in-manufacturing-facility-in-ireland-report,https://bit.ly/3AFqtd6
